InsidersTradesSigma
Follow the 东北制药 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东北制药 has published 9 reports. Market capitalisation: €6.5bn. The latest transaction was disclosed on 31 May 2022 (Purchase). Among the most active insiders: 郑伟. Every trade is free.
9
Insider Decl.
n/a
Thresholds
€201,628
9 ops.
Buy Volume
n/a
n/a
Sell Volume
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,142 of 28,880 companies
57.3
score / 100
Value70
Quality45
FCF yld15%
Earn yld4.0%
EV/EBITDA9.7x
ROE3.5%
Gross mgn37%
Net mgn3.7%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 May 2022
Declarations9 total
9 of 9 declarations
About 东北制药
Northeast Pharmaceutical is a Chinese company specializing in the manufacturing of pharmaceutical products. It is listed on the XSHE market and focuses on the development of medications for various treatments.